VSee Health Issues Additional Convertible Promissory Note to Vanquish
8-K
VSee Health, Inc. Announces 1-for-80 Reverse Stock Split
8-K
VSee Health Enters Into $5.0 Million Purchase Agreement with Clearthink Capital Partners
8-K
VSee Health, Inc. Announces Resignation of Director Scott Metzger
8-K
VSee Health, Inc. Announces Results of 2026 Annual Meeting of Stockholders
8-K
VSee Health, Inc. Receives Nasdaq Delisting Determination
Prospectus
TYPE
HEADLINE
FILED AT
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
424B3
SHARE RESALE REGISTRATION | Shares: 33,808,195
Registrations
TYPE
HEADLINE
FILED AT
S-1
ClearThink Capital Partners, LLC - SPA - 85% of the lowest close over 10 trading days before purchase (also stated as before request). Each Request Notice: up to $1 million and 300% of prior 8-day average volume; daily number not specified. No stated floor; 9.99% ownership cap.
POS EX
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]
S-1
SHARE RESALE REGISTRATION
D
Form D - Notice of Exempt Offering of Securities - Item 06b
